BIA submission to the Health Select Committee’s inquiry on AMR

The BIA has responded to the Health and Social Care Select Committee’s inquiry into how the government is responding to the challenge of antimicrobial resistance (AMR).

In our submission, we highlighted that:

• Progress has been made on improving the knowledge and understanding of AMR
• Not enough progress has been made to create a vibrant market for novel antibiotics so that biotech investors actively seek out opportunities in this area, which needs to be addressed in the updated government strategy
• BIA SME member companies working within the AMR space could give compelling oral evidence of innovation